SCHEMBL14786483

SCHEMBL14786483

O=C(Nc1cccc(C(=O)c2ccc3ncc(N4CCCC4)nc3c2)c1)c1cccc(S(=O)(=O)C(F)(F)F)c1

nearest known ligand 0.44

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 5/20 0.44
▸ TP53 P04637 2/20 0.44
▸ SMN1; SMN2 Q16637 2/20 0.44
▸ RAB9A P51151 2/20 0.44
▸ NPC1 O15118 1/20 0.44
▸ GAA P10253 1/20 0.44
▸ ALDH1A1 P00352 3/20 0.43
▸ MEN1 O00255 3/20 0.42
▸ KMT2A Q03164 3/20 0.42
▸ KDM4E B2RXH2 1/20 0.42
▸ LMNA P02545 1/20 0.42
▸ SCN10A Q9Y5Y9 3/20 0.42
▸ CNR1 P21554 1/20 0.41
▸ SIRT2 Q8IXJ6 1/20 0.41
▸ ATM Q13315 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29590409 0.88 MAPT (0.54) MAPTALDH1A1MEN1KMT2AKDM4E
SCHEMBL14783762 0.88 MAPT (0.54) MAPTALDH1A1MEN1KMT2AKDM4E
SCHEMBL29590480 0.85 MAPT (0.60) MAPTTP53SMN1; SMN2RAB9ANPC1
SCHEMBL14783338 0.85 MAPT (0.60) MAPTTP53SMN1; SMN2RAB9ANPC1
SCHEMBL28233924 0.85 MAPT (0.49) MAPTTP53SMN1; SMN2RAB9ANPC1
SCHEMBL29592435 0.83 MAPT (0.49) MAPTTP53SMN1; SMN2
SCHEMBL14783169 0.83 MAPT (0.49) MAPTTP53SMN1; SMN2
SCHEMBL14782951 0.81 BRAF (0.59) GAAKDM4E
SCHEMBL27983909 0.80 HCAR2 (0.48) MAPTTP53SMN1; SMN2ALDH1A1KDM4E
SCHEMBL14783172 0.80 MEN1 (0.47) MAPTRAB9ANPC1ALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2755657-A1 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS Neupharma, Inc. (US) 2014-07-23 — — EP disclosed
WO-2013040515-A1 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS NEUPHARMA, INC. (US) 2013-03-21 — — WO disclosed
Send feedback